LBF20000PG01: Difference between revisions
No edit summary |
No edit summary |
||
(No difference)
|
Revision as of 23:00, 19 February 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1707 |
LipidMaps | LMFA03010144 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20000PG01 |
13,14-dihydro Prostaglandin E1 | |
---|---|
Structural Information | |
9-oxo-11α,15S-dihydroxy-prostan-1-oic acid | |
| |
Formula | C20H36O5 |
Exact Mass | 356.256274262 |
Average Mass | 356.49684 |
SMILES | C(CC[C@@H](O)CC[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC |
Physicochemical Information | |
13,14-dihydro PGE1 is an inhibitor of ADP-induced platelet aggregation in human PRP. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |